Oragenics Inc.

AMEX: OGENHealthcare / Biotechnology / USA
0.4700-0.0100-2.08%Vol 564 9211Y Perf -69.01%
Jun 24th, 2019 15:59
BID0.4700 ASK0.4800
Open0.4800 Previous Close0.4900
Pre-Market0.49 After-Trading0.48
 0.01 2.08%  0.01 2.13%
Target Price
2.50 
Analyst Rating
Strong Buy 1.00
Potencial %
431.92 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★★+ —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)22 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.68 
Earnings Date
12th Aug 2019

Today's Price Range

0.47000.4800

52wk Range

0.38003.74

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-2.08%
3 Months
-21.67%
6 Months
-45.35%
1 Year
-69.01%
3 Years
-91.90%
5 Years
-97.95%

Name / TickerPriceChg.Chg.%
OGEN0.4700-0.0100-2.08
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.08-0.11-37.50
Q03 2018-0.22-0.35-59.09
Q02 2018-0.41-0.387.32
Q02 2017--0.20-
Q01 2017--0.40-
Q03 2016-0.04-0.040.00
Q02 2016--0.05-
Q01 2016--0.05-
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.0676.92Positive
9/2019 QR-0.0677.78Positive
12/2019 FY-0.3050.82Positive
12/2020 FY-0.27-28.57Negative
Next Report Date12th Aug 2019
Estimated EPS Next Report-0.06
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume564 921
Shares Outstanding (in ths.)46 112
Trades Count748
Dollar Volume260 205
Avg. Volume1 367 043
Avg. Weekly Volume390 663
Avg. Monthly Volume649 226
Avg. Quarterly Volume1 278 252
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
RatingStrong Buy
1.00
Strong Buy
1.00
-

Oragenics Inc.

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves in developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out licensing or partnering.

CEO: Alan F. Joslyn

Teplephone: +1 813 286-7900

Address: 4902 Eisenhower Boulevard, Tampa 33634, FL, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

41%59%

Bearish Bullish

46%54%

Bearish Bullish

61%39%

News